Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

NCT00004036 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myeloproliferative Disorders
Drug/Agent Toxicity by Tissue/Organ
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Precancerous Condition
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: sargramostim
DRUG: amifostine trihydrate
DRUG: carboplatin
DRUG: cyclophosphamide

Sponsor

The Cleveland Clinic